Cancer patients who smoke- care options a challenge and an opportunity for tobacco contol by Roberto Mazza

“…The social stigma represents the smoker like the only person who choose consciously the risk of cancer and worse when also during the cancer treatments he is not able to cut the chain of tobacco addiction. …”
Get full text

Real time anatomical landmarks and abnormalities detection in gastrointestinal tract by Zeshan Khan, Muhammad Atif Tahir

“…Gastrointestinal (GI) endoscopy is an active research field due to the lethal cancer diseases in the GI tract. Cancer treatments result better if diagnosed early and it increases the survival chances. …”
Get full text

Reviewing the potentials of MMOGs as research environments: A case study from the strategy game Travian by Siegfried Müller, Raji Ghawi, Jürgen Pfeffer

“…Previous research ranges from personality trait prediction to alternative cancer treatments. However, there is an ongoing debate on whether these virtual worlds are able to represent real world scenarios. …”
Get full text

Breast Cancer Presents with a Paraneoplastic Neurologic Syndrome by Pedro Coelho Barata, Joana Morgado, Ana Paula Sousa, Sónia Duarte de Oliveira, Maria Paula Custódio, Lígia Bruno da Costa, José Esteves Pena

“…Nearly one third of these patients lack detectable onconeural antibodies (ONAs), and improvement in neurologic deficits with concomitant cancer treatments is achieved in less than 30% of cases. …”
Get full text

BRAF Controls the Effects of Metformin on Neuroblast Cell Divisions in <i>C. elegans</i> by Zhi Qu, Shaoping Ji, Shanqing Zheng

“…Metformin has demonstrated substantial potential for use in cancer treatments. Liver kinase B (LKB)-AMP-activated protein kinase (AMPK) and mTOR are reported to be the main targets of metformin in relation to its ability to prevent cancer cell proliferation. …”
Get full text

Bimetallic Nanomaterials-Based Electrochemical Biosensor Platforms for Clinical Applications by Palanisamy Kannan, Govindhan Maduraiveeran

“…These applications can be as diverse as clinical diagnostics, anti-bacterial/anti-cancer treatments or biological imaging analyses, and drug delivery. …”
Get full text

Treatment-related symptom severity and occurrences among oncology adults in Australia by Violeta Lopez, Phoebe Williams, David Larkin

“…Objective: Cancer treatments cause a range of distressing symptoms that can be well managed with pharmacological and nonpharmacological interventions. …”
Get full text

Initial assessment of a model relating intratumoral genetic heterogeneity to radiological morphology. by Noterdaeme, O, Kelly, M, Friend, P, Soonowalla, Z, Steers, G, Brady, M

“…We anticipate that our model will provide a more informative way to assess the response of heterogeneous tumours to treatment, which is of increasing importance with the development of novel targeted anti-cancer treatments.…”

Tumour-stromal interactions in cancer progression and drug resistance by Picco, N

“…Its results are therefore applicable to a variety of cancer treatments that target similar processes, and whose therapeutic failure can be attributed to environment-mediated drug resistance.…”

The novel ATR inhibitor VE-821 increases sensitivity of pancreatic cancer cells to radiation and chemotherapy. by Prevo, R, Fokas, E, Reaper, P, Charlton, P, Pollard, JR, McKenna, W, Muschel, R, Brunner, T

“…These findings support ATR inhibition as a novel approach to improve the efficacy and therapeutic index of standard cancer treatments across a large proportion of pancreatic cancer patients.…”

Anti-cholangiocarcinoma cell growth and selective ability of bioactive components of ripe wild mango (Spondias pinnata) fruit extract by Supawadee Patathananone, Jureerut Daduang, Amonrat Koraneekij

“…Therefore, new anticancer agents are identified from natural resources to decrease side effects and increase the potential of cancer treatments. Ripe wild mango fruit extract which called 6A* was determined the cytotoxic effect in cholangiocarcinoma MO55 cells and a normal epithelial cell of the bile duct MMNK1 cells by using MTT assay. …”
Get full text

Exercise and Prebiotic Fiber Provide Gut Microbiota-Driven Benefit in a Survivor to Germ-Free Mouse Translational Model of Breast Cancer by Kara Sampsell, Weilan Wang, Christina Ohland, Lukas F. Mager, Nicola Pett, Dana E. Lowry, Kate M. Sales, Margaret L. McNeely, Kathy D. McCoy, S. Nicole Culos-Reed, Raylene A. Reimer

“…The gut microbiota plays a role in shaping overall host health and response to several cancer treatments. Factors, such as diet, exercise, and chemotherapy, can alter the gut microbiota. …”
Get full text

Trends in Pregnancy-Associated Cervical Cancer in Japan between 2012 and 2017: A Multicenter Survey by Sayako Enomoto, Kosuke Yoshihara, Eiji Kondo, Akiko Iwata, Mamoru Tanaka, Tsutomu Tabata, Yoshiki Kudo, Eiji Kondoh, Masaki Mandai, Takashi Sugiyama, Aikou Okamoto, Tsuyoshi Saito, Takayuki Enomoto, Tomoaki Ikeda

“…This multicenter retrospective observational study investigated clinical features and trends in pregnancy-associated cervical cancer treatments at 523 hospitals in Japan. We included cervical cancer cases that were histologically diagnosed (between 1 January 2012, and 31 December 2017), and their clinical information was retrospectively collected. …”
Get full text

The emergence of nanovaccines as a new paradigm in virological vaccinology: a review by Chittaranjan Baruah, Pankaj Das, Papari Devi, Palash Moni Saikia, Bhabesh Deka

“…Also, nanovaccines can be very helpful for making cancer treatments that use immunotherapy. So, this review highlights the various types of NPs used in the techniques that have worked in the new paradigm in viral vaccinology for infectious diseases. …”
Get full text

FDA-Approved Small Molecule Compounds as Drugs for Solid Cancers from Early 2011 to the End of 2021 by Aleksandra Sochacka-Ćwikła, Marcin Mączyński, Andrzej Regiec

“…In this work, the small molecule drugs registered by the Food and Drug Administration (FDA) for solid cancers treatment between 2011 and 2022 were identified and analyzed by investigating a type of therapy they are used for, as well as their structures and mechanisms of action. …”
Get full text

Colorectal cancer-related resource utilization and healthcare costs in Saudi Arabia by Bander Balkhi, Ahmed Alghamdi, Saeed Alqahtani, Marwan Al Najjar, Abdullah Al Harbi, Thamer Bin Traiki

“…Although numerous studies worldwide have investigated the economic burden of colorectal cancer the information specific to Saudi Arabia remains limited. While advanced cancer treatments offer substantial benefits, they they also come with substantial financial challenges. …”
Get full text

Isolation and in vivo evaluation of anti-breast cancer activity of resin glycoside merremoside from Ipomoea aquatica Forsskal in overcoming multi-drug resistance by M Sasikala, S Mohan, S Swarnakumari, A Nagarajan

“…This indicates that merromoside isolated from Ipomoea aquatica will overcome MDR (multi-drug resistance) in breast cancer especially DOX-resistant (Doxorubicin) and also it will be further used to develop drug formulations in order to overcome world challenges in cancer treatment…”
Get full text

Identification of Biochemical and Molecular Markers of Early Aging in Childhood Cancer Survivors by Silvia Ravera, Tiziana Vigliarolo, Silvia Bruno, Fabio Morandi, Danilo Marimpietri, Federica Sabatini, Monica Dagnino, Andrea Petretto, Martina Bartolucci, Monica Muraca, Eleonora Biasin, Riccardo Haupt, Marco Zecca, Franca Fagioli, Daniela Cilloni, Marina Podestà, Francesco Frassoni

“…Survival rates of childhood cancer patients have improved over the past four decades, although cancer treatments increase the risk of developing chronic diseases typical of aging. …”
Get full text

Reactive Oxygen Species-Responsive Miktoarm Amphiphile for Triggered Intracellular Release of Anti-Cancer Therapeutics by Hyun-Chul Kim, Eunjoo Kim, Se Guen Lee, Sung Jun Lee, Sang Won Jeong, Young Jae Lee, Mi Kyung Kwon, Seong-Kyoon Choi, Jun Seong Hwang, Eunsook Choi

“…Reactive oxygen species (ROS)-responsive nanocarriers have received considerable research attention as putative cancer treatments because their tumor cell targets have high ROS levels. …”
Get full text

CAR-NK Cells: A Chimeric Hope or a Promising Therapy? by Mohamad Sabbah, Ludovic Jondreville, Claire Lacan, Francoise Norol, Vincent Vieillard, Damien Roos-Weil, Stéphanie Nguyen

“…However, with recent advances in manufacturing engineered CAR-NK cells exploiting their cytolytic capacities, antibody-dependent cellular cytotoxicity (ADCC), and cytokine production, “off-the-shelf” allogeneic CAR-NK cells can provide a great potential in cancer treatments.…”
Get full text